8-KLeadership ChangesExhibits & Filings

GOLDMAN SACHS GROUP INC 8-K Report, Executive Changes (Jun 17, 2011)

Filed June 17, 2011For Securities:GSGS-PAGS-PCGS-PDGSCE

Summary

This 8-K filing from Goldman Sachs Group, Inc. (GS) announces a key change in its Board of Directors. Effective immediately, Debora L. Spar has been appointed as a new director. This appointment expands the Board to a total of eleven members. Dr. Spar's appointment is significant as she has also been assigned to several crucial Board committees: the Audit Committee, Compensation Committee, Risk Committee, and the Corporate Governance and Nominating Committee. Her inclusion in these key oversight and decision-making bodies suggests a focus on strengthening the Board's expertise in critical areas of the company's operations and governance. Investors should note the addition of a new, experienced director who will immediately contribute to the company's strategic direction and risk management.

Key Highlights

  • 1Debora L. Spar appointed to the Board of Directors, effective immediately.
  • 2Board size increases to eleven directors.
  • 3Dr. Spar appointed to the Audit Committee.
  • 4Dr. Spar appointed to the Compensation Committee.
  • 5Dr. Spar appointed to the Risk Committee.
  • 6Dr. Spar appointed to the Corporate Governance and Nominating Committee.
  • 7Press release regarding the appointment furnished as Exhibit 99.1.

Frequently Asked Questions

The filing identifies Debora L. Spar as a new director. Her specific professional background or qualifications are not detailed in this 8-K filing, but her immediate appointment to multiple key committees suggests she brings valuable experience in areas like auditing, compensation, risk, and corporate governance.

Her appointment to the Audit, Compensation, Risk, and Corporate Governance and Nominating Committees indicates an immediate and significant role in overseeing critical aspects of Goldman Sachs' operations. This includes financial reporting accuracy, executive pay, risk management strategies, and board composition/governance practices.

This 8-K filing is procedural and relates to a change in board composition, not a change in financial performance or outlook. While Dr. Spar's expertise may influence future strategic decisions and oversight, this specific filing does not directly impact the company's current financial statements or near-term financial results.

A press release detailing Dr. Spar's appointment is furnished as Exhibit 99.1 to this Form 8-K filing. Investors can review this press release for additional context and biographical information about Dr. Spar.